Length of hospital stay · children under 18 years of age with enteric fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Convalescent faecal carriage · children under 18 years of age with enteric fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · children under 18 years of age with enteric fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical failure · adults and children with enteric fever
It is very uncertain whether ceftriaxone changes clinical failure compared with fluoroquinolones (very low certainty).
1 finding from 1 review
Microbiological failure · adults and children with enteric fever
It is very uncertain whether ceftriaxone changes microbiological failure compared with fluoroquinolones (very low certainty).
1 finding from 1 review
Relapse · adults and children with enteric fever
It is very uncertain whether ceftriaxone changes relapse compared with fluoroquinolones (very low certainty).
1 finding from 1 review
Time to defervescence · adults and children with enteric fever
It is very uncertain whether ceftriaxone changes time to defervescence compared with fluoroquinolones (very low certainty).
1 finding from 1 review
Length of hospital stay · adults and children with enteric fever
1 finding from 1 review
Microbiological failure · adults and children with enteric fever
Cefixime showed no clear difference in microbiological failure compared with fluoroquinolones (low certainty).
1 finding from 1 review
Convalescent faecal carriage · adults and children with enteric fever
It is very uncertain whether ceftriaxone changes convalescent faecal carriage compared with fluoroquinolones (very low certainty).
1 finding from 1 review
Serious adverse events · adults and children with enteric fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · adults and children with enteric fever
Cefixime may leads to higher relapse compared with fluoroquinolones (low certainty).
1 finding from 1 review
Time to defervescence · adults and children with enteric fever
Cefixime may leads to higher time to defervescence compared with fluoroquinolones (low certainty).
1 finding from 1 review
Length of hospital stay · adults and children with enteric fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Convalescent faecal carriage · adults and children with enteric fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · adults and children with enteric fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical failure · children under 18 years of age with enteric fever
Ceftriaxone showed no clear difference in clinical failure compared with azithromycin (low certainty).
1 finding from 1 review
Microbiological failure · children under 18 years of age with enteric fever
It is very uncertain whether ceftriaxone changes microbiological failure compared with azithromycin (very low certainty).
1 finding from 1 review
All‐cause mortality · people with cancer who have febrile neutropenia
Pre‐emptive antifungal therapy showed no clear difference in all‐cause mortality compared with empirical antifungal therapy (low certainty).
1 finding from 1 review
Mortality ascribed to fungal infection · people with cancer who have febrile neutropenia
Pre‐emptive antifungal therapy showed no clear difference in mortality ascribed to fungal infection compared with empirical antifungal therapy (low certainty).
1 finding from 1 review